banner
GPR inhibitor APD668, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ577

GPR inhibitor APD668, Purity ≥98%

Synonym: 832714-46-2; GPR inhibitor; APD 668; APD-668; JNJ-28630368; JNJ28630368; JNJ 28630368

  • MDL: MFCD12032117
  • CAS Number: 832714-46-2
  • Compound CID: 11705608
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
APD668, soluble in DMSO and ethanol and insoluble in water, is a compound that specifically targets and inhibits G protein-coupled receptors (GPRs), which play a critical role in transmitting signals across cell membranes. It targets CYP2C9, hERG channel, hGPR119, and rGPR119.
Molecular Weight
477.51
Molecular Formula
C21H24FN5O5S
Targets
CYP2C9: 0.1 μM (Ki); hERG channel: 3 μM; hGPR119: 2.7 μM; rGPR119: 33 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 86 mg/mL (180.1 mM); Water: Insoluble; Ethanol: 86 mg/mL (180.1 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
APD668 is studied in the context of its inhibitory effects on certain GPR receptors, relevant to diabetes and metabolic research.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0